158 related articles for article (PubMed ID: 21115105)
1. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
Vrzal R; Doricakova A; Novotna A; Bachleda P; Bitman M; Pavek P; Dvorak Z
Toxicol Lett; 2011 Feb; 200(3):146-53. PubMed ID: 21115105
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia.
Pascussi JM; Robert A; Nguyen M; Walrant-Debray O; Garabedian M; Martin P; Pineau T; Saric J; Navarro F; Maurel P; Vilarem MJ
J Clin Invest; 2005 Jan; 115(1):177-86. PubMed ID: 15630458
[TBL] [Abstract][Full Text] [Related]
3. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
5. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site.
Nutchey BK; Kaplan JS; Dwivedi PP; Omdahl JL; Ferrante A; May BK; Hii CS
Biochem J; 2005 Aug; 389(Pt 3):753-62. PubMed ID: 15836435
[TBL] [Abstract][Full Text] [Related]
6. Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells.
Amano Y; Cho Y; Matsunawa M; Komiyama K; Makishima M
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):144-51. PubMed ID: 19429444
[TBL] [Abstract][Full Text] [Related]
7. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
[TBL] [Abstract][Full Text] [Related]
8. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
Anderson PH; O'Loughlin PD; May BK; Morris HA
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
Anderson PH; O'Loughlin PD; May BK; Morris HA
Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
[TBL] [Abstract][Full Text] [Related]
10. Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells.
Armbrecht HJ; Hodam TL; Boltz MA; Partridge NC; Brown AJ; Kumar VB
Endocrinology; 1998 Aug; 139(8):3375-81. PubMed ID: 9681485
[TBL] [Abstract][Full Text] [Related]
11. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.
Swami S; Krishnan AV; Peehl DM; Feldman D
Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619
[TBL] [Abstract][Full Text] [Related]
12. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS
J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978
[TBL] [Abstract][Full Text] [Related]
13. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin.
Nakano H; Matsunawa M; Yasui A; Adachi R; Kawana K; Shimomura I; Makishima M
Biochem Pharmacol; 2005 Nov; 70(10):1479-86. PubMed ID: 16183038
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells.
Peng X; Tiwari N; Roy S; Yuan L; Murillo G; Mehta RR; Benya RV; Mehta RG
J Endocrinol; 2012 Feb; 212(2):207-15. PubMed ID: 22068926
[TBL] [Abstract][Full Text] [Related]
16. Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3.
Chun RF; Gacad M; Nguyen L; Hewison M; Adams JS
J Mol Endocrinol; 2007 Aug; 39(2):81-9. PubMed ID: 17693608
[TBL] [Abstract][Full Text] [Related]
17. Regulation of somatostatin expression by vitamin D3 and valproic acid in human adipose-derived mesenchymal stem cells.
Doering L; Khatri R; Petry SF; Sauer H; Howaldt HP; Linn T
Stem Cell Res Ther; 2019 Aug; 10(1):240. PubMed ID: 31387633
[TBL] [Abstract][Full Text] [Related]
18. Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia.
Hosseinpour F; Ellfolk M; Norlin M; Wikvall K
Biochem Biophys Res Commun; 2007 Jun; 357(3):603-7. PubMed ID: 17445763
[TBL] [Abstract][Full Text] [Related]
19. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
20. Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.
Alimirah F; Vaishnav A; McCormick M; Echchgadda I; Chatterjee B; Mehta RG; Peng X
Mol Cell Biochem; 2010 Sep; 342(1-2):143-50. PubMed ID: 20440542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
